vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and Direct Digital Holdings, Inc. (DRCT). Click either name above to swap in a different company.

Direct Digital Holdings, Inc. is the larger business by last-quarter revenue ($8.4M vs $8.1M, roughly 1.0× Arcellx, Inc.). Direct Digital Holdings, Inc. runs the higher net margin — -138.7% vs -766.0%, a 627.3% gap on every dollar of revenue. On growth, Direct Digital Holdings, Inc. posted the faster year-over-year revenue change (-7.4% vs -79.3%). Over the past eight quarters, Arcellx, Inc.'s revenue compounded faster (-24.6% CAGR vs -38.6%).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

Devolver Digital, Inc. is an American video game publisher based in Austin, Texas, specializing in the publishing of indie games. The company was founded in June 2009 by Nigel Lowrie, Harry Miller, Graeme Struthers, Rick Stults, and Mike Wilson, five executives who had been involved with Gathering of Developers and Gamecock Media Group, which published games on developer-friendly terms, but due to the high cost associated with releasing retail games saw themselves acquired and dissolved by la...

ACLX vs DRCT — Head-to-Head

Bigger by revenue
DRCT
DRCT
1.0× larger
DRCT
$8.4M
$8.1M
ACLX
Growing faster (revenue YoY)
DRCT
DRCT
+71.9% gap
DRCT
-7.4%
-79.3%
ACLX
Higher net margin
DRCT
DRCT
627.3% more per $
DRCT
-138.7%
-766.0%
ACLX
Faster 2-yr revenue CAGR
ACLX
ACLX
Annualised
ACLX
-24.6%
-38.6%
DRCT

Income Statement — Q1 FY2025 vs Q4 FY2025

Metric
ACLX
ACLX
DRCT
DRCT
Revenue
$8.1M
$8.4M
Net Profit
$-62.3M
$-11.7M
Gross Margin
26.8%
Operating Margin
-847.6%
-53.4%
Net Margin
-766.0%
-138.7%
Revenue YoY
-79.3%
-7.4%
Net Profit YoY
-765.1%
-434.7%
EPS (diluted)
$-1.13
$-74.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
DRCT
DRCT
Q4 25
$8.4M
Q3 25
$8.0M
Q2 25
$10.1M
Q1 25
$8.1M
$8.2M
Q4 24
$15.3M
$9.1M
Q3 24
$26.0M
$9.1M
Q2 24
$27.4M
$21.9M
Q1 24
$39.3M
$22.3M
Net Profit
ACLX
ACLX
DRCT
DRCT
Q4 25
$-11.7M
Q3 25
$-2.7M
Q2 25
$-2.2M
Q1 25
$-62.3M
$-2.4M
Q4 24
$-47.1M
$-2.2M
Q3 24
$-25.9M
$-2.7M
Q2 24
$-27.2M
$-590.0K
Q1 24
$-7.2M
$-775.0K
Gross Margin
ACLX
ACLX
DRCT
DRCT
Q4 25
26.8%
Q3 25
27.7%
Q2 25
35.1%
Q1 25
29.3%
Q4 24
32.5%
Q3 24
38.7%
Q2 24
27.1%
Q1 24
22.4%
Operating Margin
ACLX
ACLX
DRCT
DRCT
Q4 25
-53.4%
Q3 25
-49.0%
Q2 25
-23.9%
Q1 25
-847.6%
-48.1%
Q4 24
-348.2%
-51.8%
Q3 24
-129.1%
-40.3%
Q2 24
-127.8%
-9.4%
Q1 24
-40.3%
-12.6%
Net Margin
ACLX
ACLX
DRCT
DRCT
Q4 25
-138.7%
Q3 25
-33.6%
Q2 25
-22.2%
Q1 25
-766.0%
-28.9%
Q4 24
-308.4%
-24.0%
Q3 24
-99.4%
-29.6%
Q2 24
-99.3%
-2.7%
Q1 24
-18.3%
-3.5%
EPS (diluted)
ACLX
ACLX
DRCT
DRCT
Q4 25
$-74.97
Q3 25
$-0.24
Q2 25
$-0.23
Q1 25
$-1.13
$-0.35
Q4 24
$-0.87
$-90.17
Q3 24
$-0.48
$-0.71
Q2 24
$-0.51
$-0.16
Q1 24
$-0.14
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
DRCT
DRCT
Cash + ST InvestmentsLiquidity on hand
$543.3M
$728.0K
Total DebtLower is stronger
Stockholders' EquityBook value
$416.9M
$-7.0M
Total Assets
$648.1M
$20.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
DRCT
DRCT
Q4 25
$728.0K
Q3 25
$871.0K
Q2 25
$1.6M
Q1 25
$543.3M
$1.8M
Q4 24
$587.4M
$1.4M
Q3 24
$574.3M
$4.1M
Q2 24
$516.7M
$1.1M
Q1 24
$573.9M
$3.3M
Total Debt
ACLX
ACLX
DRCT
DRCT
Q4 25
Q3 25
$10.8M
Q2 25
$33.5M
Q1 25
$32.9M
Q4 24
Q3 24
$150.0K
Q2 24
$34.8M
Q1 24
$32.4M
Stockholders' Equity
ACLX
ACLX
DRCT
DRCT
Q4 25
$-7.0M
Q3 25
$-6.7M
Q2 25
$-24.6M
Q1 25
$416.9M
$-23.3M
Q4 24
$454.8M
$-19.7M
Q3 24
$483.0M
$-16.7M
Q2 24
$487.2M
$-10.5M
Q1 24
$496.6M
$-7.5M
Total Assets
ACLX
ACLX
DRCT
DRCT
Q4 25
$20.2M
Q3 25
$22.5M
Q2 25
$23.3M
Q1 25
$648.1M
$23.8M
Q4 24
$711.3M
$26.0M
Q3 24
$764.9M
$31.3M
Q2 24
$734.3M
$48.5M
Q1 24
$779.7M
$52.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
DRCT
DRCT
Operating Cash FlowLast quarter
$-63.1M
$-1.9M
Free Cash FlowOCF − Capex
$-63.9M
FCF MarginFCF / Revenue
-786.4%
Capex IntensityCapex / Revenue
9.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-122.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
DRCT
DRCT
Q4 25
$-1.9M
Q3 25
$-1.6M
Q2 25
$-2.7M
Q1 25
$-63.1M
$-2.7M
Q4 24
$-46.0M
$-1.6M
Q3 24
$30.7M
$3.0M
Q2 24
$-36.2M
$-4.4M
Q1 24
$-31.9M
$-5.7M
Free Cash Flow
ACLX
ACLX
DRCT
DRCT
Q4 25
Q3 25
Q2 25
Q1 25
$-63.9M
Q4 24
$-47.5M
Q3 24
$28.4M
Q2 24
$-39.5M
Q1 24
$-38.3M
FCF Margin
ACLX
ACLX
DRCT
DRCT
Q4 25
Q3 25
Q2 25
Q1 25
-786.4%
Q4 24
-311.3%
Q3 24
109.2%
Q2 24
-144.1%
Q1 24
-97.7%
Capex Intensity
ACLX
ACLX
DRCT
DRCT
Q4 25
Q3 25
Q2 25
Q1 25
9.6%
Q4 24
9.8%
Q3 24
8.8%
Q2 24
11.7%
Q1 24
16.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACLX
ACLX

Segment breakdown not available.

DRCT
DRCT

Buy Side Advertising$8.2M98%
Other$183.0K2%

Related Comparisons